Benjamin M. Johnson
Impact in
- Pharmaceutical Science top 0.5%
- Fluorine in Organic Chemistry
- Organic Chemistry top 5%
- Catalytic C–H Functionalization Methods
- Radical Photochemical Reactions
- Cyclopropane Reaction Mechanisms
Papers in
-
- Gut microbiota and health 7
- Genetics 7
- Diabetes and associated disorders 6
- Co-authors
- Yue‐Zhong Shu (6 shared papers)Xiaoliang Zhuo (5 shared papers)Nicholas A. Meanwell (4 shared papers)Chenthamarakshan Vasu (14 shared papers)Radhika Gudi (13 shared papers)Richard B. van Breemen (4 shared papers)Subha Karumuthil‐Melethil (4 shared papers)Nicolas Pérez (4 shared papers)
- Journals
- Chemical Research in Toxicology (4 papers)Drug Metabolism and Disposition (4 papers)Immunology (3 papers)Diabetes (3 papers)Clinical & Experimental Immunology (2 papers)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
Benjamin M. Johnson
44 papers receiving 1.5k citations
Benjamin M. Johnson's Hit Papers
Peers
Comparison fields: 5 of 125
- Pharmaceutical Science 400
- Organic Chemistry 415
- Pharmacology 119
- Gastroenterology 62
- Inorganic Chemistry 129
Countries citing papers authored by Benjamin M. Johnson
This map shows the geographic impact of Benjamin M. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin M. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin M. Johnson more than expected).
Fields of papers citing papers by Benjamin M. Johnson
This network shows the impact of papers produced by Benjamin M. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin M. Johnson. The network helps show where Benjamin M. Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin M. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Metabolic and Pharmaceutical Aspects of Fluorinated Compounds Hit paper breakdown → | 2020 | 539 |
| 2 | 2015 | 113 | |
| 3 | 2013 | 93 | |
| 4 | 2002 | 79 | |
| 5 | 2014 | 61 | |
| 6 | 2003 | 53 | |
| 7 | 2008 | 53 | |
| 8 | 2019 | 49 | |
| 9 | 2019 | 45 | |
| 10 | 2020 | 42 | |
| 11 | 2021 | 39 | |
| 12 | 2019 | 32 | |
| 13 | 2003 | 31 | |
| 14 | 2017 | 31 | |
| 15 | 2015 | 31 | |
| 16 | 2010 | 28 | |
| 17 | 2014 | 25 | |
| 18 | 2001 | 25 | |
| 19 | 2020 | 20 | |
| 20 | 2015 | 18 |
About Benjamin M. Johnson
Benjamin M. Johnson is a scholar working on Molecular Biology, Genetics, Infectious Diseases, Organic Chemistry and Pharmacology, having authored 45 papers that have together received 1.6k indexed citations. Recurring topics across this work include Gut microbiota and health (7 papers), Diabetes and associated disorders (6 papers), Hepatitis C virus research (4 papers), Systemic Lupus Erythematosus Research (4 papers), Immune Cell Function and Interaction (4 papers), Gastrointestinal motility and disorders (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Pharmaceutical Science (400 citations), Organic Chemistry (415 citations), Pharmacology (119 citations), Gastroenterology (62 citations) and Inorganic Chemistry (129 citations). Benjamin M. Johnson has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Yue‐Zhong Shu, Xiaoliang Zhuo, Nicholas A. Meanwell, Chenthamarakshan Vasu, Radhika Gudi, Richard B. van Breemen, Subha Karumuthil‐Melethil, Nicolas Pérez, M. Hanief Sofi and Dejan Nikolić. Their work appears in journals such as Chemical Research in Toxicology, Drug Metabolism and Disposition, Immunology, Diabetes and Clinical & Experimental Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.